New nonalcoholic beer crafted specifically for cancer patients

Michael Walter | | Radiology Business | Practice Management

A new beer being served in the Czech Republic was crafted with a very specific audience in mind: cancer patients undergoing chemotherapy.

The beverage, called Mamma Beer, is nonalcoholic, according to a report from NPR. It is meant to counteract dysgeusia, a common side effect of chemotherapy that ruins the taste of most food and drinks. The team behind Mamma Beer is also involved with Mamma HELP, a nonprofit breast cancer advocacy group in the Czech Republic.

"Chemotherapy in breast cancer patients often causes a loss in taste or a change of taste that leads to a lower intake of nutrients than patients need during their treatment," said Karolina Hovorkova, MD, as quoted by NPR. Hovorkova has been serving samples of the drink to her patients in Prague since April.

Click below to read the full story.

Czech Company Designs A Nonalcoholic Beer To Taste Good To Cancer Patients

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Radiology group cancels hospital-based business to focus on outpatient center growth
Radiology provider Akumin breaks long radio silence after emerging from bankruptcy
Doc offices more than double use of nonphysicians for interpreting medical images
Patients frequently fail to obtain follow-up imaging. Could radiologist-referrer disagreements be to blame?
3 modifiable factors that make radiology reports easier for patients to understand
Academic radiologists earn less than peers in the specialty, but the gap is closing

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.